secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLGATE PALMOLIVE CO (CL)
CIK:        0000021665
Form:       8-K
Filed at:   2023-01-27T23:59:59+00:00
Accession:  0001157523-23-000106
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Colgate Q4 organic sales +8.5%; GAAP EPS $2.13 (-16%) on Filorga impairment
---------------------------------------------------------------------------

- Q4 net sales +5.0%, organic sales +8.5%, with growth in every division and category.
- Full year net sales $17,967M (+3.0%), organic sales +7.0% – fourth consecutive year above 3–5% target.
- GAAP EPS $2.13, down 16% YoY, driven by goodwill/intangibles impairment charges on Filorga skin health business.
- Base Business (non-GAAP) EPS $2.97, down 7% YoY, in line with full-year guidance.
- Management cites revenue growth management and productivity initiatives funding increased innovation and advertising.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/21665/000115752323000106/0001157523-23-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/21665/000115752323000106/a53291858.htm
  HTML page:      https://secwatch.observer/filing/0001157523-23-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer